Vir Biotechnology, Inc. (VIR)
12.21
+1.19
(+10.80%)
USD |
NASDAQ |
Nov 06, 16:00
12.30
+0.09
(+0.74%)
After-Hours: 20:00
Vir Biotechnology Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -197.14M |
| March 31, 2026 | 11.84M |
| December 31, 2025 | 86.65M |
| September 30, 2025 | 40.45M |
| June 30, 2025 | 56.46M |
| March 31, 2025 | 126.82M |
| December 31, 2024 | 140.74M |
| September 30, 2024 | 118.60M |
| June 30, 2024 | 211.61M |
| March 31, 2024 | 28.42M |
| December 31, 2023 | -104.81M |
| September 30, 2023 | -58.95M |
| June 30, 2023 | 230.32M |
| March 31, 2023 | 98.18M |
| December 31, 2022 | -153.14M |
| September 30, 2022 | -662.60M |
| Date | Value |
|---|---|
| June 30, 2022 | -272.33M |
| March 31, 2022 | -105.39M |
| December 31, 2021 | -377.58M |
| September 30, 2021 | 73.86M |
| June 30, 2021 | 75.38M |
| March 31, 2021 | 87.53M |
| December 31, 2020 | 60.71M |
| September 30, 2020 | -185.38M |
| June 30, 2020 | 10.58M |
| March 31, 2020 | 104.22M |
| December 31, 2019 | -73.77M |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | 16.10M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Moderna, Inc. | 329.00M |
| Vaxcyte, Inc. | 170.77M |
| Arrowhead Pharmaceuticals, Inc. | 43.68M |
| Oncolytics Biotech, Inc. | 0.00 |
| Sangamo Therapeutics, Inc. | -0.013M |
Cash from Investing (Quarterly) Related Metrics
| Free Cash Flow | -203.59M |
| Free Cash Flow Per Share (Quarterly) | 0.7301 |
| Free Cash Flow to Equity (Quarterly) | 125.60M |
| Free Cash Flow to Firm (Quarterly) | 123.29M |
| Free Cash Flow Yield | -11.22% |